Pulse Biosciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $27.3M | $2.8M |
| Jun 2017 | — | $24.2M | $2.0M |
| Sep 2017 | — | $49.9M | $32.4M |
| Dec 2017 | — | $46.0M | $3.4M |
| Mar 2018 | — | $41.1M | $10.7M |
| Jun 2018 | — | $35.0M | $6.8M |
| Sep 2018 | — | $28.1M | $6.3M |
| Dec 2018 | — | $66.3M | $51.1M |
| Mar 2019 | — | $59.1M | $8.5M |
| Jun 2019 | — | $49.9M | $10.8M |
| Sep 2019 | — | $41.0M | $9.6M |
| Dec 2019 | — | $30.7M | $6.9M |
| Mar 2020 | — | $21.8M | $7.9M |
| Jun 2020 | — | $42.3M | $37.8M |
| Sep 2020 | — | $32.7M | $7.1M |
| Dec 2020 | — | $22.9M | $12.5M |
| Mar 2021 | — | $20.4M | $59.9M |
| Jun 2021 | — | $59.8M | $47.4M |
| Sep 2021 | — | $47.4M | $42.0M |
| Dec 2021 | — | $44.4M | $44.4M |
| Mar 2022 | — | $20.8M | $12.7M |
| Jun 2022 | — | $23.4M | $14.8M |
| Sep 2022 | — | $6.2M | $69.2M |
| Dec 2022 | — | $-2.2M | $61.1M |
| Mar 2023 | — | $-10.7M | $54.1M |
| Jun 2023 | — | $60.5M | $58.7M |
| Sep 2023 | — | $52.1M | $50.4M |
| Dec 2023 | — | $44.4M | $44.4M |
| Mar 2024 | — | $36.3M | $34.9M |
| Jun 2024 | — | $27.0M | $26.2M |
| Sep 2024 | — | $79.1M | $79.0M |
| Dec 2024 | — | $114.9M | $118.0M |
| Mar 2025 | — | $118.5M | $119.3M |
| Jun 2025 | — | $104.5M | $106.3M |
| Sep 2025 | — | $92.7M | $95.2M |
| Dec 2025 | — | $80.7M | $80.7M |
| Mar 2026 | — | $66.3M | $68.3M |
| Jun 2026 | — | $99.5M | $101.6M |